- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/20 - Interférons
Détention brevets de la classe C12N 15/20
Brevets de cette classe: 30
Historique des publications depuis 10 ans
|
0
|
1
|
1
|
0
|
4
|
2
|
1
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Purdue Research Foundation | 3776 |
2 |
| Institute of Biophysics, Chinese Academy of Sciences | 138 |
2 |
| Novagen Holding Corporation | 20 |
2 |
| Aeras Global TB Vaccine Foundation | 14 |
1 |
| Amarillo Biosciences, Inc. | 6 |
1 |
| AOBiome LLC | 103 |
1 |
| Commonwealth Scientific and Industrial Research Organisation | 1665 |
1 |
| Fudan University | 724 |
1 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 997 |
1 |
| ImmunGene Inc. | 12 |
1 |
| Mat Malta Advanced Technologies Limited | 11 |
1 |
| Metabolic Explorer | 185 |
1 |
| National University of Singapore | 2533 |
1 |
| Peking University | 1382 |
1 |
| Pfenex Inc. | 24 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
1 |
| The United States of America, as represented by the Secretary, Dept. of Health and Human Services | 142 |
1 |
| Universidad de Concepcion | 121 |
1 |
| Hudson Institute of Medical Research | 52 |
1 |
| Cytopharm, Inc. | 1 |
1 |
| Autres propriétaires | 7 |